Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses

Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses

Objectives: In the present study, we aimed to determine the candidate genes that may function as biomarkers to further distinguish patients with isocitrate dehydrogenase (IDH)-wildtype glioblastoma (GBM), which are heterogeneous with respect to clinical outcomes.Materials and Methods: We selected 41...

Full description

Bibliographic Details
Main Authors: Yu-Qing Liu, Fan Wu, Jing-Jun Li, Yang-Fang Li, Xing Liu, Zheng Wang, Rui-Chao Chai
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-12-01
Series:Frontiers in Oncology
Subjects:
glioma
GBM
IDH wildtype
risk signature
biomarker
prognosis
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01433/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01433/full

Similar Items